Gilead Sciences, Inc.
GILD
$114.00
-$0.43-0.38%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 24.77% | -42.55% | 54.45% | -512.87% | -12.87% |
| Total Depreciation and Amortization | 0.73% | 0.88% | 1.91% | 7.81% | 30.30% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -97.31% | 292.71% | 100.36% | 868.24% | 110.99% |
| Change in Net Operating Assets | 188.95% | 141.45% | -567.07% | 15.31% | -564.10% |
| Cash from Operations | 37.16% | 145.53% | -43.33% | 27.24% | -15.50% |
| Capital Expenditure | 31.63% | -15.57% | 6.47% | 3.67% | -18.78% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 73.12% | -621.52% | 37.45% | -633.76% | -27.98% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 98.71% | 103.57% | 75.25% | 1,269.28% | -1,070.83% |
| Cash from Investing | 69.05% | -210.04% | 36.44% | -167.19% | -93.87% |
| Total Debt Issued | 346,300.00% | -- | -- | -- | -- |
| Total Debt Repaid | -- | 95.02% | -- | -- | -- |
| Issuance of Common Stock | 565.38% | 18.07% | -80.77% | 50.52% | -85.23% |
| Repurchase of Common Stock | -133.33% | 0.00% | 33.33% | 0.00% | 81.06% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -3.18% | -3.15% | -2.97% | -2.17% | -3.06% |
| Other Financing Activities | -42.42% | -5.13% | -6.06% | 12.69% | -43.48% |
| Cash from Financing | 305.64% | 9.22% | -168.21% | 3.20% | 29.28% |
| Foreign Exchange rate Adjustments | -248.65% | 833.33% | -184.62% | -238.46% | -50.67% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1,203.95% | 226,300.00% | -353.39% | -187.18% | -46.70% |
